Eventide Healthcare & Life Sciences Fd Cl I Profit Margin

The latest profit margin for ETIHX is -136.13% as of May 2023. That compares with 989.03% in the prior-year period — down 113.8% year over year. That is below the sector sector average of 13.23%. Investors often review this figure alongside Eventide Healthcare & Life Sciences Fd Cl I's historical trend and sector peers before judging valuation or financial health.

Over the past year, ETIHX's profit margin moved from 989.03% to -136.13% — a 113.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Eventide Healthcare & Life Sciences Fd Cl I's valuation or profitability profile.

Against its sector companies, ETIHX currently prints -136.13% for profit margin, while the sector average sits near 13.23%. That is roughly 1129.3% below the sector mean. Large gaps often invite a closer look at Eventide Healthcare & Life Sciences Fd Cl I's growth, margins, and balance sheet.

Profit Margin shows how effectively Eventide Healthcare & Life Sciences Fd Cl I converts resources into returns. At -136.13%, ETIHX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 989.03% in the prior-year period — down 113.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ETIHX's profit margin (-136.13%), review year-over-year change from 989.03%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.